A randomized, double-blind study of hydromorphone hydrochloride extended-release tablets versus oxycodone hydrochloride extended-release tablets for cancer pain: efficacy and safety in Japanese cancer patients (EXHEAL: a Phase III study of EXtended-release HydromorphonE for cAncer pain reLief)

ダウンロード数 : ? 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/53427

言語	英語
著者	Inoue Satoshi Clinical Development Department, R&D Division, Daiichi Sankyo, Tokyo 齊藤洋司 Tsuneto Satoru Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto Aruga Etsuko Department of Palliative Medicine, School of Medicine, Teikyo University, Tokyo Ide Azusa Clinical Development Department, R&D Division, Daiichi Sankyo Kakurai Yasuyuki Biostatistics and Data Management Department, R&D Division, Daiichi Sankyo, Tokyo, Japan
主題	hydromorphone; oxycodone; cancer pain; palliative medicine; double-blind study
掲載誌名	JOURNAL OF PAIN RESEARCH
巻	10
開始ページ	1953
終了ページ	1961
ISSN	1178-7090
発行日	2017
DOI	10.2147/JPR.S136937
PubMed ID	28860850
出版者	DOVE MEDICAL PRESS LTD
資料タイプ	学術雑誌論文
部局	医学部
備考	This study and preparation of this report were funded by Daiichi Sankyo Co Ltd. The authors wish to thank all of the investigators at the participating centers (see Box S1) for their contribution to this study. We would also like to thank Marion Barnett of Edanz Medical Writing for providing editorial support.